Medicilon Founder Chen Chunlin: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
PharmAsia News' China Bureau recently spoke with Chen Chunlin, founder of Shanghai-based Medicilon, about the advantages and disadvantages for Western companies seeking partnerships with Chinese firms to conduct preclinical research, and the growth of Medicilon since its founding in 2003. U.S.-based MPI Research and Medicilon recently entered a joint venture to establish a preclinical research center in Shanghai that meets U.S. FDA and other international regulatory standards (PharmAsia News, Jan. 2, 2008)
You may also be interested in...
Insider Analysis From BioForesight: Navigating the Life Sciences Silk Road Frontier
By Zhu Shen, Chief Executive Officer, BioForesight
Insider Analysis From BioForesight: Navigating the Life Sciences Silk Road Frontier
By Zhu Shen, Chief Executive Officer, BioForesight
China’s WuXi To Acquire U.S.-Based AppTec Laboratory Services
SHANGHAI - WuXi PharmaTech will acquire U.S.-based AppTec Laboratory Services, the Chinese pharma outsourcing company announced Jan. 3